BIOCHEMICAL DIAGNOSTICS, INC.

LGC Clinical Diagnostics is a global manufacturer specializing in quality management tools, reagent components, biological materials, and diagnostic solutions for the in vitro diagnostics (IVD) and life sciences sectors. As a division of the LGC Group, the company integrates expertise from multiple brands including Technopath Clinical Diagnostics, SeraCare, Biochemical Diagnostics, Kova International, Maine Standards, and The Native Antigen Company. The company manufactures comprehensive portfolios of catalog and custom-developed diagnostic quality solutions, serving over 27,500 customers worldwide including IVD manufacturers, clinical laboratories, biopharmaceutical companies, and academic institutions. Products and services include quality controls, reference materials, linearity and calibration verification solutions, antigens and antibodies, drugs of abuse quality controls, urinalysis quality controls, and external quality assessment (EQA) proficiency testing programs. All facilities are FDA-registered and certified to ISO 13485 and ISO 9001 standards, demonstrating commitment to quality and regulatory compliance throughout the diagnostic pipeline from early research to routine clinical use.